Lindbrook Capital, LLC Iovance Biotherapeutics, Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 2,984 shares of IOVA stock, worth $22,081. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,984

Previous 2,692 10.85%

Holding current value

$22,081

Previous $21,000 33.33%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$7.28 - $11.9 $2,125 - $3,474	292 Added 10.85%	2,984 $28,000
Q2 2024 Jul 31, 2024	BUY	$7.78 - $14.19 $342 - $624	44 Added 1.66%	2,692 $21,000
Q1 2024 Apr 25, 2024	BUY	$7.59 - $17.47 $265 - $611	35 Added 1.34%	2,648 $39,000
Q4 2023 Jan 31, 2024	BUY	$3.3 - $8.89 $3,560 - $9,592	1,079 Added 70.34%	2,613 $21,000
Q3 2023 Oct 25, 2023	BUY	$4.44 - $8.79 $790 - $1,564	178 Added 13.13%	1,534 $6,000
Q2 2023 Jul 28, 2023	SELL	$5.36 - $9.06 $5,971 - $10,092	-1,114 Reduced 45.1%	1,356 $9,000
Q1 2023 Apr 26, 2023	SELL	$5.53 - $8.22 $4,075 - $6,058	-737 Reduced 22.98%	2,470 $15,000
Q4 2022 Jan 24, 2023	BUY	$5.62 - $10.0 $12,543 - $22,320	2,232 Added 228.92%	3,207 $0
Q3 2022 Nov 10, 2022	SELL	$9.53 - $13.11 $428 - $589	-45 Reduced 4.41%	975 $9,000
Q2 2022 Aug 01, 2022	SELL	$6.38 - $18.33 $567 - $1,631	-89 Reduced 8.03%	1,020 $11,000
Q1 2022 Apr 21, 2022	SELL	$12.38 - $19.1 $198 - $305	-16 Reduced 1.42%	1,109 $18,000
Q4 2021 Jan 18, 2022	BUY	$16.55 - $27.63 $17,427 - $29,094	1,053 Added 1462.5%	1,125 $21,000
Q3 2021 Nov 05, 2021	SELL	$20.35 - $26.63 $976 - $1,278	-48 Reduced 40.0%	72 $2,000
Q2 2021 Jul 27, 2021	BUY	$16.33 - $33.07 $1,959 - $3,968	120 New	120 $3,000
Q1 2021 Apr 28, 2021	BUY	$28.67 - $52.59 $0 - $0	0 New	0 $0
Q3 2020 Nov 03, 2020	SELL	$27.75 - $36.3 $27,750 - $36,300	-1,000 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$27.21 - $41.0 $27,210 - $41,000	1,000 New	1,000 $27,000
Q1 2020 Apr 22, 2020	SELL	$19.54 - $38.85 $9,770 - $19,425	-500 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$17.95 - $29.41 $8,975 - $14,705	500 New	500 $14,000
Q2 2019 Jul 24, 2019	SELL	$9.78 - $24.52 $7,334 - $18,390	-750 Closed	0 $0
Q1 2019 Apr 23, 2019	BUY	$8.41 - $11.26 $6,307 - $8,445	750 New	750 $7,000

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.17B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Iovance Biotherapeutics, Inc. Transaction History